ALLR
Price:
$1.16
Market Cap:
$16.85M
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 cli...[Read more]
Industry
Biotechnology
IPO Date
2021-12-21
Stock Exchange
NASDAQ
Ticker
ALLR
According to Allarity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.13. This represents a change of -113.25% compared to the average of -0.98 of the last 4 quarters.
The mean historical PE Ratio of Allarity Therapeutics, Inc. over the last ten years is -6.72. The current 0.13 PE Ratio has changed -293.53% with respect to the historical average. Over the past ten years (40 quarters), ALLR's PE Ratio was at its highest in in the September 2021 quarter at 12.17. The PE Ratio was at its lowest in in the December 2020 quarter at -72.02.
Average
-6.72
Median
-0.12
Minimum
-55.31
Maximum
0
Discovering the peaks and valleys of Allarity Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -55.31
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.08 | -99.86% |
| 2023 | -55.31 | 31.63% |
| 2022 | -0.17 | -92.96% |
| 2021 | -2.48 | -63.36% |
| 2020 | -6.76 | 183.86% |
| 2019 | -2.38 | -Infinity% |
| 2018 | 0 | 0% |
| 2017 | 0 | 0% |
| 2016 | 0 | 0% |
| 2015 | 0 | -100.00% |
The current PE Ratio of Allarity Therapeutics, Inc. (ALLR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-18.52
5-year avg
-12.96
10-year avg
-6.72
Allarity Therapeutics, Inc.’s PE Ratio is greater than Cingulate Inc. (-0.00), greater than Processa Pharmaceuticals, Inc. (-0.00), greater than BriaCell Therapeutics Corp. (-2.36), greater than Lexaria Bioscience Corp. (-1.80), greater than Entero Therapeutics, Inc. (-0.25), greater than Lixte Biotechnology Holdings, Inc. (-3.74), greater than Clearside Biomedical, Inc. (-0.18), greater than Kairos Pharma, Ltd. (-3.63), greater than Curis, Inc. (-0.58), greater than CASI Pharmaceuticals, Inc. (-0.32),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $22.09M | |
| -0.00 | $15.36M | |
| -2.36 | $23.06M | |
| -1.80 | $20.27M | |
| -0.25 | $11.06M | |
| -3.74 | $19.34M | |
| -0.18 | $4.97M | |
| -3.63 | $18.86M | |
| -0.58 | $17.45M | |
| -0.32 | $15.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allarity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Allarity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Allarity Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Allarity Therapeutics, Inc. (ALLR)?
What is the highest PE Ratio for Allarity Therapeutics, Inc. (ALLR)?
What is the 3-year average PE Ratio for Allarity Therapeutics, Inc. (ALLR)?
What is the 5-year average PE Ratio for Allarity Therapeutics, Inc. (ALLR)?
How does the current PE Ratio for Allarity Therapeutics, Inc. (ALLR) compare to its historical average?